Rautio, Elina
Gadler, Fredrik
Gudbjörnsdottir, Soffia
Franzén, Stefan
Rydén, Lars
Savarese, Gianluigi
Svensson, Ann-Marie
Mellbin, Linda G.
Funding for this research was provided by:
The Swedish Heart- and Lung foundation (20220412, 20220412)
The Region of Stockholm and the Swedish government (20200424)
Karolinska Institute
Article History
Received: 5 September 2023
Accepted: 1 December 2023
First Online: 6 January 2024
Declarations
:
: Oral or written consent was obtained from all patients included in the NDR. For the purpose of this registry-based study all patients and controls were assigned individual codes. The analyses were carried out with coded data. The study, which was conducted in agreement with the Declaration of Helsinki, was approved by the Central Ethical Review Board in Gothenburg, Sweden (DNR: 776-14, 2014-11-24).
: Not applicable.
: GS reports grants and personal fees from Vifor, grants and non-financial support from Boehringer Ingelheim, personal fees from Societa´ Prodotti Antibiotici, grants and personal fees from AstraZeneca, personal fees from Roche, personal fees from Servier, grants from Novartis, personal fees from GENESIS, personal fees from Cytokinetics, personal fees from Medtronic, grants from Boston Scientific, grants from PHARMACOSMOS, grants from Merck, grants from Bayer, outside the submitted work.